Exosome– tag –
-
BIANCA CLINIC Pioneers Regenerative Medicine in Japan with Autologous Adipose Stem Cells and Exosome Therapy under Strict Regulatory Compliance
BIANCA CLINIC Japan Overview BIANCA CLINIC in Tokyo is advancing regenerative medicine by offering exosome therapy, purified stem cell culture supernatant, and autologous adipose-derived stem cell therapy, all strictly compliant with Jap... -
IV Exosome Therapy: Under Investigation for Cell Behavior Modulation and Anti-Inflammation, FDA Not Yet Approved
Sanger Wellness Center USA Overview Exosomes, tiny extracellular vesicles involved in intercellular communication, are being investigated for their potential to influence cell behavior, inflammatory pathways, tissue response, and recover... -
Exosome Therapy Revolutionizes Skin Treatment: Promotes Cell Regeneration and Anti-Inflammation Without Physical Injury
Dr Azra Vaziri USA Overview Exosome therapy harnesses tiny extracellular vesicles secreted by stem cells to deliver biological signals for cell repair and regeneration to skin cells. Unlike traditional dermapen or microneedling, this tre... -
Breakthrough: Schwann Cell Exosomes Dramatically Improve Recovery from Severe Peripheral Nerve Injuries
The Miami Project USA Overview Researchers at the University of Miami Miller School of Medicine have demonstrated in preclinical models that exosomes derived from Schwann cells significantly accelerate functional recovery following sever... -
Japan’s Stem Cell Therapy Landscape: High Costs and Strict MHLW Regulations Govern Regenerative Medicine Hubs
PlacidWay Japan Overview Leading stem cell therapy clinics in Japan, such as Cell Grand Clinic and Clinique Haru Osaka Umeda, offer regenerative medicine for conditions like joint disorders, musculoskeletal diseases, diabetes, and Parkin... -
FibroBiologics Secures U.S. Patent (No. 12,721,866) for Wound Healing with 3D Spheroid Fibroblasts, Targeting Chronic and Acute Wounds
Stock Titan USA Overview FibroBiologics announced the issuance of U.S. Patent No. 12,721,866 on September 1, 2026, for the therapeutic use of fibroblasts in wound healing. This patent covers the topical administration of 3D spheroid fibr... -
KOLON Biotech Expands Comprehensive CDMO Services in Korea, Specializing in Cell, Gene, and Exosome Therapies
MTEC South Korea Overview KOLON Biotech in South Korea is bolstering its capabilities as a specialized Contract Development and Manufacturing Organization (CDMO) for advanced cell, gene, and exosome therapies. The company offers end-to-e... -
KOLON Biotech Boosts End-to-End CDMO Services for Advanced Cell, Gene, and Exosome Therapies in South Korea
MTEC South Korea Overview South Korea's KOLON Biotech is enhancing its comprehensive CDMO services, specializing in advanced cell, gene, and exosome therapies. The company offers end-to-end solutions, from technology transfer and process... -
Decoding Hashimoto’s: Exosomes Emerge as Pivotal for Diagnosis and Therapy
PubMed International Overview A groundbreaking study reveals the critical role of exosomes in the pathogenesis of Hashimoto's thyroiditis, positioning them as promising new diagnostic biomarkers and therapeutic targets. The research deta... -
Exosome-Based Therapeutics Development Summit Convenes in Boston to Address Manufacturing, Regulatory, and Clinical Challenges
Hanson Wade Conferences USA Overview The 8th Exosome-Based Therapeutics Development Summit will be held in Boston from September 22-24, 2026, focusing on overcoming challenges in scalable manufacturing, robust analytical characterization...
